Annual FCF
-$138.42 M
+$145.36 M+51.22%
December 31, 2023
Summary
- As of February 7, 2025, FATE annual free cash flow is -$138.42 million, with the most recent change of +$145.36 million (+51.22%) on December 31, 2023.
- During the last 3 years, FATE annual FCF has fallen by -$94.25 million (-213.43%).
- FATE annual FCF is now -1039.51% below its all-time high of -$12.15 million, reached on December 31, 2011.
Performance
FATE Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$29.91 M
+$2.44 M+7.55%
September 30, 2024
Summary
- As of February 7, 2025, FATE quarterly free cash flow is -$29.91 million, with the most recent change of +$2.44 million (+7.55%) on September 30, 2024.
- Over the past year, FATE quarterly FCF has increased by +$8.92 million (+22.98%).
- FATE quarterly FCF is now -178.30% below its all-time high of $38.20 million, reached on June 30, 2020.
Performance
FATE Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$132.53 M
+$8.92 M+6.31%
September 30, 2024
Summary
- As of February 7, 2025, FATE TTM free cash flow is -$132.53 million, with the most recent change of +$8.92 million (+6.31%) on September 30, 2024.
- Over the past year, FATE TTM FCF has increased by +$51.14 million (+27.84%).
- FATE TTM FCF is now -3263.58% below its all-time high of -$3.94 million, reached on March 31, 2013.
Performance
FATE TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
FATE Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +51.2% | +23.0% | +27.8% |
| 3 y3 years | -213.4% | +6.7% | +45.0% |
| 5 y5 years | -238.0% | -7.8% | -33.8% |
FATE Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +51.2% | at high | +66.3% | at high | +54.4% |
| 5 y | 5-year | -213.4% | +51.2% | -178.3% | +66.3% | -241.9% | +54.4% |
| alltime | all time | -1039.5% | +51.2% | -178.3% | +66.3% | -3263.6% | +54.4% |
Fate Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$29.91 M(-7.6%) | -$132.53 M(-6.3%) |
| Jun 2024 | - | -$32.36 M(-3.2%) | -$141.45 M(+1.2%) |
| Mar 2024 | - | -$33.44 M(-9.2%) | -$139.78 M(+1.0%) |
| Dec 2023 | -$138.42 M(-51.2%) | -$36.82 M(-5.2%) | -$138.42 M(-24.6%) |
| Sep 2023 | - | -$38.84 M(+26.5%) | -$183.66 M(-11.9%) |
| Jun 2023 | - | -$30.69 M(-4.3%) | -$208.55 M(-13.5%) |
| Mar 2023 | - | -$32.07 M(-60.9%) | -$241.15 M(-15.0%) |
| Dec 2022 | -$283.77 M(+32.9%) | -$82.07 M(+28.8%) | -$283.77 M(-2.3%) |
| Sep 2022 | - | -$63.72 M(+0.7%) | -$290.37 M(+5.7%) |
| Jun 2022 | - | -$63.29 M(-15.3%) | -$274.76 M(+6.8%) |
| Mar 2022 | - | -$74.70 M(-15.8%) | -$257.19 M(+20.4%) |
| Dec 2021 | -$213.57 M(+383.6%) | -$88.66 M(+84.3%) | -$213.57 M(+44.5%) |
| Sep 2021 | - | -$48.11 M(+5.2%) | -$147.85 M(+12.5%) |
| Jun 2021 | - | -$45.73 M(+47.1%) | -$131.43 M(+176.7%) |
| Mar 2021 | - | -$31.08 M(+35.5%) | -$47.49 M(+7.5%) |
| Dec 2020 | -$44.16 M(-51.2%) | -$22.94 M(-27.6%) | -$44.16 M(-10.5%) |
| Sep 2020 | - | -$31.69 M(-182.9%) | -$49.35 M(+27.3%) |
| Jun 2020 | - | $38.20 M(-237.7%) | -$38.77 M(-60.9%) |
| Mar 2020 | - | -$27.74 M(-1.4%) | -$99.07 M(+9.4%) |
| Dec 2019 | -$90.57 M(+121.2%) | -$28.13 M(+33.3%) | -$90.57 M(+21.4%) |
| Sep 2019 | - | -$21.10 M(-4.5%) | -$74.58 M(+29.1%) |
| Jun 2019 | - | -$22.10 M(+14.9%) | -$57.76 M(+21.7%) |
| Mar 2019 | - | -$19.24 M(+58.5%) | -$47.46 M(+15.9%) |
| Dec 2018 | -$40.95 M | -$12.14 M(+183.6%) | -$40.95 M(+1.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | -$4.28 M(-63.7%) | -$40.33 M(-12.7%) |
| Jun 2018 | - | -$11.80 M(-7.3%) | -$46.19 M(+5.8%) |
| Mar 2018 | - | -$12.73 M(+10.6%) | -$43.67 M(+13.3%) |
| Dec 2017 | -$38.54 M(+27.3%) | -$11.52 M(+13.7%) | -$38.54 M(+11.3%) |
| Sep 2017 | - | -$10.13 M(+9.1%) | -$34.62 M(+8.1%) |
| Jun 2017 | - | -$9.28 M(+22.0%) | -$32.03 M(+5.2%) |
| Mar 2017 | - | -$7.61 M(+0.3%) | -$30.46 M(+0.6%) |
| Dec 2016 | -$30.28 M(+52.2%) | -$7.59 M(+0.6%) | -$30.28 M(+1.5%) |
| Sep 2016 | - | -$7.55 M(-2.1%) | -$29.84 M(-0.8%) |
| Jun 2016 | - | -$7.71 M(+3.8%) | -$30.07 M(+46.7%) |
| Mar 2016 | - | -$7.43 M(+3.9%) | -$20.50 M(+3.0%) |
| Dec 2015 | -$19.89 M(-14.6%) | -$7.15 M(-8.2%) | -$19.89 M(+3.8%) |
| Sep 2015 | - | -$7.79 M(-517.3%) | -$19.17 M(+12.2%) |
| Jun 2015 | - | $1.87 M(-127.3%) | -$17.09 M(-30.2%) |
| Mar 2015 | - | -$6.83 M(+6.3%) | -$24.48 M(+5.0%) |
| Dec 2014 | -$23.30 M(+49.2%) | -$6.42 M(+12.6%) | -$23.30 M(+7.9%) |
| Sep 2014 | - | -$5.71 M(+3.5%) | -$21.60 M(+11.4%) |
| Jun 2014 | - | -$5.51 M(-2.4%) | -$19.39 M(+11.9%) |
| Mar 2014 | - | -$5.65 M(+19.6%) | -$17.33 M(+11.0%) |
| Dec 2013 | -$15.62 M(+11.7%) | -$4.73 M(+35.3%) | -$15.62 M(+43.4%) |
| Sep 2013 | - | -$3.50 M(+1.2%) | -$10.89 M(+47.3%) |
| Jun 2013 | - | -$3.45 M(-12.3%) | -$7.39 M(+87.7%) |
| Mar 2013 | - | -$3.94 M | -$3.94 M |
| Dec 2012 | -$13.98 M(+15.1%) | - | - |
| Dec 2011 | -$12.15 M | - | - |
FAQ
- What is Fate Therapeutics annual free cash flow?
- What is the all time high annual FCF for Fate Therapeutics?
- What is Fate Therapeutics annual FCF year-on-year change?
- What is Fate Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Fate Therapeutics?
- What is Fate Therapeutics quarterly FCF year-on-year change?
- What is Fate Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Fate Therapeutics?
- What is Fate Therapeutics TTM FCF year-on-year change?
What is Fate Therapeutics annual free cash flow?
The current annual FCF of FATE is -$138.42 M
What is the all time high annual FCF for Fate Therapeutics?
Fate Therapeutics all-time high annual free cash flow is -$12.15 M
What is Fate Therapeutics annual FCF year-on-year change?
Over the past year, FATE annual free cash flow has changed by +$145.36 M (+51.22%)
What is Fate Therapeutics quarterly free cash flow?
The current quarterly FCF of FATE is -$29.91 M
What is the all time high quarterly FCF for Fate Therapeutics?
Fate Therapeutics all-time high quarterly free cash flow is $38.20 M
What is Fate Therapeutics quarterly FCF year-on-year change?
Over the past year, FATE quarterly free cash flow has changed by +$8.92 M (+22.98%)
What is Fate Therapeutics TTM free cash flow?
The current TTM FCF of FATE is -$132.53 M
What is the all time high TTM FCF for Fate Therapeutics?
Fate Therapeutics all-time high TTM free cash flow is -$3.94 M
What is Fate Therapeutics TTM FCF year-on-year change?
Over the past year, FATE TTM free cash flow has changed by +$51.14 M (+27.84%)